MyFinsight
Home
Blog
About
Total royalties
$59,790K
Xacduro
$22,382K
Giapreza
$22,299K
Xerava
$6,739K
ZEVTERA
$351K
Royalty
$56,334K
Product
$51,771K
License And Other
Revenue
$11,486K
Less amortization of
capitalized fees paid
$3,456K
Total revenue
$119,591K
(19.25%↑ Y/Y)
Net income (loss)
and comprehensive...
-$83,420K
(-230.98%↓ Y/Y)
Income tax benefit
(expense), net
-$24,600K
(-376.09%↓ Y/Y)
Gross profit
$90,616K
(8.98%↑ Y/Y)
Cost of products sold
(inclusive of amortization...
$22,349K
(111.04%↑ Y/Y)
Amortization of acquired
intangible assets
$6,626K
(1.21%↑ Y/Y)
Income (loss) before
income taxes
-$108,020K
(-248.79%↓ Y/Y)
Income from operations
$50,855K
(4.32%↑ Y/Y)
Interest and dividend
income
$7,599K
(54.29%↑ Y/Y)
Total operating
expenses
$39,761K
(15.60%↑ Y/Y)
Changes in fair values of
equity method...
-$131,834K
(-1107.75%↓ Y/Y)
Changes in fair values of
equity and long-term...
-$29,153K
(-358.45%↓ Y/Y)
Interest expense
$5,472K
(17.35%↑ Y/Y)
Other expense, net
-$15K
(98.07%↑ Y/Y)
Selling, general and
administrative
$34,571K
(30.89%↑ Y/Y)
Research and development
$5,190K
(-34.99%↓ Y/Y)
Back
Back
Income Statement
Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA)
source: myfinsight.com